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Abstract
Background: The National Institutes of Health has called for expansion of practice-based research to improve the
clinical research enterprise.
Methods: This paper presents a model for the reorganization of clinical research to foster long-term participation
by community clinicians.
Based on the literature and interviews with clinicians and other stakeholders, we posited a model, conducted
further interviews to test the viability of the model, and further adapted it.
Results: We propose a three-dimensional system of checks and balances to support community clinicians using
research support organizations, community outreach, a web-based registry of clinicians and studies, web-based
training services, quality audits, and a feedback mechanism for clinicians engaged in research.
Conclusions: The proposed model is designed to offer a systemic mechanism to address current barriers that
prevent clinicians from participation in research. Transparent mechanisms to guarantee the safety of patients and
the integrity of the research enterprise paired with efficiencies and economies of scale are maintained by
centralizing some of the functions. Assigning other responsibilities to more local levels assures flexibility with
respect to the size of the clinician networks and the changing needs of researchers.
Introduction
“The scale and complexity of today’sb i o m e d i c a l
research problems increasingly demand that scientists
move beyond the confines of their own discipline and
explore new organizational models for team science [1].”
With this statement, Dr. Elias Zerhouni galvanized the
research community to consider how best to “reengineer
the clinical research enterprise” and “develop new part-
nerships among organized patient communities, com-
munity-based clinicians, and academic researchers.” In
two previous articles, we identified specific barriers
community clinicians face in participating in clinical
research and laid out specific strategies that will facili-
tate participation of these clinicians and their associated
healthcare organizations in clinical research [2,3]. How-
ever, these strategies alone are insufficient for recruiting
and supporting enough community-based clinicians to
“reengineer” the clinical research enterprise. Rather,
more systematic changes to the infrastructure of the
research enterprise will be required [4].
The current system relies heavily on two methods for
recruiting and supporting clinicians in research. The tra-
ditional method relies on principal investigators (PIs)
and research teams to recruit clinicians into studies [5].
The second, newer system involves collaborative net-
works of clinicians and healthcare communities inter-
ested in research [6,7]. Both strategies have had some
success, but not nearly enough to populate the current-
or future-multiple, large-scale clinical studies needed to
test the efficacy of a new generation of biomedical and
genetically engineered interventions [4,8]. For both of
these methods, recruiting clinicians and patients for
each new study is time-intensive, expensive, and ineffi-
cient [9,10]. Further, clinicians who agree to participate
in these studies often feel overly burdened and poorly
reimbursed, provide data of variable quality, and are
reluctant to participate in future work [10,11]. Although
clinical trial networks (CTNs) and practice-based
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successful in engaging clinicians in multiple studies over
time, CTNs typically involve collaborations of small
groups of clinicians (e.g., 50 to 200 for most CTNs),
whereas PBRNs are not in a position to provide suffi-
cient infrastructural support to consistently engage clini-
cians over time [1]. To meet the dual goals of recruiting
and retaining large numbers of community clinicians in
research over a period of time, this paper proposes an
alternative for reengineering the research system. This
paper describes the components and interrelationships
of such a system, the advantages the system would offer,
the requirements for such a system to work, and
expected measurable outcomes.
Methods
We were funded by the National Institutes of Health
(NIH) as a component of the roadmap to help develop a
conceptual model for a system that would allow a large
number of clinicians to participate in clinical research
while they care for patients in their office settings. To
accomplish this goal, we conducted a classic formative
evaluation [13,14]. Formative evaluations help develop
and improve programs from an early stage by (a) identi-
fying the size and scope of key issues, (b) generating and
selecting among potential solutions, and (c) adapting
existing interventions to fit cultural and organizational
c u l t u r e s .T ot h i se n d ,w ef i r s ti d e n t i f i e dt h em a i np r o -
blems with and potential solutions to the current
research system via a review of the literature and in-
depth interviews with community and academic clini-
cians and other key stakeholders in the current research
enterprise. For our literaturer e v i e w s ,w er e l i e do nb o t h
k e y w o r ds e a r c h e sa sw e l la ss u g g e s t i o n sf r o mt h o s ep e o -
ple we interviewed, where we focused primarily on clini-
cal trials, PBRNs, and quality improvement collaboratives
(e.g., the Institute for Healthcare Improvement) [15]. We
began to develop our initial model only after we reached
a point where additional interviews and searches were
revealing few new ideas. We then refined the model and
confirmed its feasibility by interviewing additional clini-
cians and stakeholders, as well as returning to interview
some of those who we had spoken with previously.
Details of the methodology are described in companion
manuscripts [2,3].
The RAND Institutional Review Board reviewed these
materials and procedures prior to the start of the
interviews.
Results
A three-dimensional approach to supporting the
involvement of community clinicians in clinical research
Our research suggests that any approach that attempts
to engage and maintain large numbers of community
clinicians in the research enterprise will need to take
into account three dimensions (Figure 1). First, for any
approach to work, it must result in the creation of a
large, diverse, and stable network of clinicians who will
participate in both clinical research and clinical care
[2,3]. Second, to assist this network, a well-integrated
set of services must be established to identify, recruit,
retain, and support those clinicians in a manner consis-
tent with the standards that characterize high-quality
research. Third, to ensure consistency and quality across
the network, an administrative and coordinating capacity
will be needed to oversee the functions of the network
and its provision of services. Table 1 contrasts the tasks
and responsibilities of the current system with our pro-
posed three-dimensional research system. For example,
in the current system, ongoing support for clinicians
and staff collecting the data is varied and dependent on
available resources and the capacity of PIs, CTNs, and
PBRNs. In the proposed approach, ongoing support is
more consistent across studies and research sites and
delivered by well-supported and incentivized research
support organizations (RSOs).
These three dimensions should work together as a
vehicle to further the efficiency and productivity of
research; create networks that are diverse and represen-
tative of all healthcare and research stakeholders by
engaging significantly more managed care, fee-for-
service, and safety-net providers from diverse commu-
nities; and promote a wide variety of studies applicable
to large numbers of patients. In addition, this three-
dimensional approach offers a structure for organizing
incentives and administering finances associated with
research conducted in clinical settings. It can be charac-
terized as a flexible tool to be shared across all funders
of clinical research (potentially including, e.g.,t h eN I H
or individual institutes within it, pharmaceutical compa-
nies, specialty societies, and even the RSOs themselves).
 
Support Services
a 
 
Providers engaged in 
research in the context of 
clinical care 
 
Central Administration 
Figure 1 The three dimensions of a reengineered research
enterprise.
aThe set of support services include research support
organizations (RSOs), community outreach, a web-based registry of
providers and studies (ROPS), web-based training services, quality
audits, and a feedback mechanism for clinicians engaged in
research in the context of clinical care.
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Approximately 3% of physicians in the United States
serve as investigators [16], and these are typically in
association with academic health centers. Although no
accurate source for the total number of community phy-
sicians involved in research could be identified, the Fed-
eration of Practice-Based Research Networks’ Inventory
of Networks lists approximately 9,750 physicians (1% to
2% of American physicians) as members [17].
Recruiting and maintaining a stable network of com-
munity clinicians would reduce the time and effort that
have been needed to recruit and train such clinicians
each time a study is begun. A stable network of commu-
nity clinicians, including specialists in family medicine,
pediatrics, and internal medicine as well as other com-
munity clinicians (e.g., obstetric/gynecologist physicians,
dentists, and nurse practitioners), and subspecialists
would gain experience across time and facilitate the
conduct of diverse studies with diverse patient partici-
pants [4,8]. A large, diverse, experienced set of clinicians
would accommodate implementation of many study
designs, both sequentially and simultaneously.
An integrated set of services for supporting participating
clinicians
In the current system, the kinds and amounts of support
given to clinicians vary across studies and are deter-
mined primarily by the resources available to PIs, CTNs,
and PBRNs. Variation in resources and support across
studies makes it difficult for community physicians to
estimate whether they can afford to participate in
research on an ongoing basis. To motivate a stable
cadre of clinicians to integrate research into their
practices, a variety of support services will need to be
developed and implemented predictably for all clini-
cians, regardless of specialty or previous experience.
Research support organizations
To recruit, support, and retain clinicians and to over-
come the innumerable barriers and disincentives that
clinicians face in participating in clinical research, RSOs
will be needed to directly interface with and support the
unique needs of clinicians and their clinical settings as
they attempt to conduct clinical research [3]. These
organizations could be formed by academic health cen-
ters, academic research organizations, PBRNs, clinical
research organizations, CTNs, multispecialty groups,
health management organizations (HMOs), community
hospitals, or clinical practices. They could evolve from
the newly funded NIH-sponsored Clinical Translational
Science Awards (CTSAs). Based on RAND’s estimations
of network size and our assumption that RSOs will
probably be most responsive if they limit their services
to no more than 1,500 clinicians at a time, we estimate
that approximately 30 to 40 RSOs will be needed to
cover the full range of geographic, ethnic, and medical
diversity in the country while achieving appropriate
economies of scale (see below).
RSOs will develop a systems approach based upon
their collective experience and knowledge but will work
locally with individual clinicians to recruit clinicians to
(a) participate in a stable research program, assist them
in the registration process, help match them with appro-
priate studies, and address any initial clinician questions
and concerns; (b) work with individual clinicians to
reorganize office infrastructure to facilitate research,
Table 1 Research tasks and responsibilities in the current system and the proposed reengineered research enterprise
Key Research Tasks Current System Proposed Approach
Research design PIs PIs
Protocol development PIs PIs, with input from clinician panel
Recruitment of clinicians PIs recruit for single studies; CTNs and PBRNs recruit for
multiple studies but are often discipline- and disease-
specific
ROPS acts as the source for a large pool of studies; RSOs
recruit for multiple studies across disciplines and diseases
Training
General research
training
Usually incorporated into study-specific training by PIs Web-based training
Study-specific training PIs PIs, with option to link to web-based training
Ongoing support for
clinicians and staff
collecting data
Varied and dependent on available resources and capacity
by PIs, CTNs, PBRNs
More consistent across studies and research sites and
delivered by well-supported and incentivized RSOs
Quality assurance PIs Quality assurance at the site level; PIs for data
Clinician feedback Via PIs Via PIs, ROPS, RSOs, and protocol review panels
Use of study results PIs via direct communication and peer-reviewed articles ROPS to entire relevant network, not just to those who
participated in the study; plus PIs via peer-reviewed
articles
PI = principal investigator; CTN = clinical trial network; PBRN = practice-based research network; ROPS = registry of providers and services; RSO = research
support organization.
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patient recruitment efforts; (c) provide easily accessible
support to help reduce the day-to-day burden of pro-
blem solving for office staff; and (d) take responsibility
for encouraging clinicians to remain in the network
after completing their first study [3].
One of the research support organizations’ key roles
will be to help reduce the day-to-day problem solving
and research burden that typically falls to the office
staff. This can be done through a range of mechanisms,
including employment of an adequate number of pro-
fessional research coordinators, trainers, and problem
solvers and the provision of online and printed
resources for clinicians and staff. RSOs also will need to
recognize the critical role that personal and trusted rela-
tionships play in establishing and maintaining network
participation.
RSOs will need to be reimbursed for their efforts by
a central administrative function (see below). Ideally,
RSOs will be incentivized to assist community clini-
cians to engage in research via market principles of
competition. Clinicians, who would be free to change
RSOs at will, would gravitate toward those RSOs that
provide the best combination of services relative to
requirements. The central administrative function and
its more hands-on affiliates (RSOs) will need to be
flexible about the specific strategies used to support
clinicians so RSOs can be free to work innovatively
with clinicians to achieve their goals. To maintain
quality and uniformity in the services provided and the
clinicians recruited, RSOs will need to engage with the
administration and adhere to established standards for
retaining membership.
However, even when RSOs are available to provide gui-
dance and support, five additional types of services will
be required to help initiate and sustain community clini-
cian engagement: community outreach, a registry of pro-
viders and studies (ROPS), web-based training services,
quality audits, and a clinician feedback mechanism.
Community outreach
Currently, most community outreach efforts are study-
specific, with few resources dedicated to fostering
broader, more long-term relationships between commu-
nity clinicians and the research enterprise. Long-term
outreach would engage community members and clini-
cians by providing research-related opportunities and
information, reducing the burden to participate in
research, and soliciting advice and feedback about the
research process. Clinicians, for example, would be
updated about research opportunities available to them
and their patients and reminded of the importance of
clinical research to clinicians and their professional
organizations and the value patients derive from
research conducted in community settings. A strong
community outreach approach would also foster greater
clinician and community participation in the design and
implementation of the research itself. Seeking clinician
and community engagement and feedback would help
ensure that study designs and logistics were more likely
to take into consideration the realities and constraints of
community practices and that communities would have
a greater voice in identifying the research questions and
topics that were most relevant to them. This suggestion
is consistent with the RE-AIM (research, effectiveness,
adoption, implementation, maintenance) framework, one
of several evaluation frameworks developed to support
the assessment of interventions in terms of the translat-
ability and public health impact of health promotion
[18-20].
Registry of providers and studies
Once providers are informed of a new initiative to
recruit them to long-term research participation, they
will need to be able to register their interests and learn
about salient study opportunities. A web-based ROPS
could provide this service, listing clinicians’ names, spe-
cialties, interests, and research experience in terms of
completed training, studies initiated, and patients
enrolled. Although some clinician recruitment is popula-
tion-based, with attention paid to long-term clinician
involvement [21], much is done in an ad hoc manner,
with little attention paid to systematically monitoring or
encouraging clinician involvement across multiple
studies.
Web-based training services
To ensure that clinicians and key office staff have basic
research skills, web-based training, allowing clinicians
and staff to participate at their convenience without
leaving their clinical practices, should be provided and
its completion documented in clinicians’ registry pro-
files. Although some study-specific training and quality
assurance procedures would be needed, a standardized
approach to these activities across studies, sites, clini-
cians, and staff should provide substantial economies of
scale and opportunities for improved research outcomes.
Currently, basic research training is often incorporated
into study-specific training, increasing the burden on
clinicians and staff who engage in multiple studies.
Quality audits
To ensure that research environments foster high qual-
ity research, RSOs might institute and oversee a quality
assurance program that will conduct routine audits
within the clinicians’ offices. These efforts will assure
clinicians, as well as other stakeholders, that research
conducted in their offices is of the highest quality.
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Currently, clinicians who participate in clinical trials have
little voice in designing those studies and even less influ-
ence on the research enterprise as a whole [21]. When
clinicians have concerns about protocols, enrollment,
data, and/or reimbursement, they should be able to com-
municate those concerns through the registry and/or
with their RSOs. At the national level, the registry would
collect concerns and issues identified by clinicians and
their staff. These concerns would be aggregated and
passed on to both PIs as well as the appropriate NIH
funding sources. At the local level, RSOs would be
responsible for collecting and responding to such clini-
cians’ concerns. Since RSOs are also responsible for
motivating clinicians to participate and supporting them,
they have a vested interest in listening and responding to
clinician concerns. In this way, clinicians will be assured
that their voices are heard, particularly with respect to
quality and safety concerns, throughout the research
process.
An administrative and coordinating center
To support the network of clinicians and deliver the six
categories of services described above, a central struc-
ture with coordinating capacity will be required. This
central structure would administer the web-based regis-
tries and training programs; oversee the quality assur-
ance process; select, manage, and remunerate the core
group of RSOs; and facilitate feedback mechanisms
among PIs, RSOs, and clinicians. The key role of the
administrative personnel would be to take the lead in
making this three-dimensional structure, and its poten-
tial impact on the clinical research enterprise, a reality.
Advantages of a three-dimensional system
Establishing a diverse representation of clinicians,
patients, and treatment settings for a wide array of stu-
dies that will be applicable to a large segment of the
patient population, with results available for review and
dissemination by community clinicians as well as by
academic researchers (thus providing a deeper under-
standing of the underlying biology and promoting inter-
disciplinary research teams), is ambitious. Yet a
well-coordinated program would enhance the overall
quality and efficiency of the clinical research enterprise
by introducing transparency and accountability to
enhance safeguards for data quality and engender
greater trust among clinicians and the public [22]. Hav-
ing a stable network of clinicians would, in the long run
(e.g., 10 or more years), lead to efficiencies in patient
recruitment, data collection, and data transfer, as well as
to a more stable pool of researchers and patients who
are readily engaged in clinical research. If implemented
carefully, the visibility of this reengineered research
enterprise should lead to increases in research participa-
tion by clinicians and patients and increases in public
trust in clinical research. Ultimately, such increases are
likely to promote uses of clinical research findings into
communities and facilitate the delivery of better care.
Using a three-dimensional approach also provides the
potential for checks and balances across the three dimen-
sions that will allow safe, efficient, and effective conduct
of research by community clinicians. Each of the three
proposed dimensions can implement procedures or con-
trols to ensure that high-quality data collection standards
are met and human subjects are protected. The central
administrative structure could take responsibility for
maintaining the registry, conducting quality audits, and
providing mechanisms for clinician feedback. RSOs could
be responsible for coordinating services associated with
recruitment and clinician support and could also consult
with those responsible for the registry and quality assur-
ance in deciding on the appropriate and measurable indi-
cators to use in assessing study-specific and across-study
performance. Properly aligned incentives will reward a
research support organization’s effort for recruiting and
sustaining large numbers of clinicians in high quality
research. Finally, clinicians could indicate their satisfac-
tion with an RSO via the clinician feedback mechanism
and through their actual rate of participation with clinical
research. If clinicians “vote with their feet” by not enrol-
ling patients or by disengaging in the research enterprise,
that information could be fed back to ROPS and, ulti-
mately, to the central administration.
The administrative and financial implications of this
proposed system are nontrivial. Although there are some
administrative and financial costs needed to oversee the
national program (including the development and main-
tenance of the registry), most of the resources will be
allocated to local RSOs. The RSOs will receive the most
administrative and financial resources because they are
the most critical and proximate component for removing
burdens and barriers from community clinicians and
their staff. Although the CTSA has made strides in this
direction, much of their community engagement has
been on a study-by-study basis. In contrast, our approach
advocates for a program that will establish a stable
national network of local community practices. The net-
work of community practices would have the ability to
engage in a wide range of research opportunities and
would be funded by the various institutes of the NIH that
wished to have access to such a network.
We would expect that the various institutes of the NIH
would fund the national infrastructure and contribute sig-
nificantly to the initial development of RSOs. Over time,
however, we would expect that the federal contribution to
RSOs would diminish. RSOs stand to gain in terms of
prestige and/or profit if they are able to successfully
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of community providers. Since consortiums of organiza-
tions will have to compete with each other to become
RSOs and RSOs will compete with each other to attract
studies funded by either the NIH or the pharmaceutical
industry, we would anticipate that RSOs would contribute
at least some resources (directly or in kind) to the develop-
ment and maintenance of their research network. As RSOs
become more efficient, they should be able to recover a
higher portion of their infrastructural costs directly from
studies and thus begin to move toward self-sufficiency.
How might we measure the success or failure of such a
system?
Several measures might be used to gauge the success of
this effort (Table 2). For example, after implementing
the new system, we might expect to see improvements
in the number, diversity, and representativeness of
patients involved in clinical research, as well as improve-
ment in the kinds of direct and indirect care that such
patients receive in practices engaged in research. Like-
w i s e ,w ew o u l de x p e c tt os e em o r ec l i n i c i a n sw i t h
greater diversity engaged in clinical research, with less
turnover and greater satisfaction with the research pro-
cess. If such a system were designed and implemented
as suggested, we would expect to see the number and
diversity of patients, clinicians, and RSOs involved in
clinical research increase over time. The scope, number,
and size of studies should also increase, and more stu-
dies should be completed on time and on budget. If the
quality control mechanisms are properly enabled, we
should also expect higher quality data and increases in
patient, clinician, and RSO satisfaction and public trust.
While some of these outcomes are easy to quantify
because they are consistent with explicitly stated goals,
others are more conceptual, unanticipated, and only
likely to translate into highly valued results with time.
Discussion
We have proposed a general design for a large, well-sup-
ported, stable system to increase the participation of com-
munity clinicians in clinical research that includes a set of
checks and balances between a network of clinicians, a set
of service providers, and a small administrative structure.
The proposed design specifically recognizes that any ser-
ious effort to involve large numbers of community clini-
cians in clinical research must address the current barriers
that prevent more clinicians from participation and must
include transparent mechanisms to guarantee the safety of
patients and the integrity of the research enterprise. Effi-
ciencies and economies of scale are maintained by centra-
lizing some of the functions, while assigning other
responsibilities to more local levels. The system is also
designed to be scalable in terms of the size of the clinician
network and adaptable to the changing needs of research-
ers. Thus, the system might be adapted for use as a single
national program or across a region, a state, or a large
group of academic and/or managed care affiliates.
The rationale for developing this program is the sim-
ple notion that engaging more community clinicians in
Table 2 Potential measures for evaluating the success or failure of a reengineered research enterprise relative to its
major stakeholders
Patients Clinicians Research support
organizations (RSOs)
NIH and the biomedical research
enterprise
a) Number, diversity, and
representativeness of patients involved
with CR
a) Number, diversity, and
representativeness of clinicians
and settings involved with CR
a) Number of organizations
engaged in the support of CR
a) Efficiency of the CR process (e.g.,
measured as the number of studies
completed as planned on schedule)
b) Safety of patients involved with CR b) Number of studies and types
of studies in which clinicians
participate
b) Number of studies and
types of studies in which RSOs
participate
b) Number of studies being conducted
c) Retention throughout the tenure of
the research study; participation rates
in long-term outcome studies
c) Degree of engagement of
clinicians with components of
CR
c) Degree of engagement of
RSOs with components of CR
c) Distribution of study types being
conducted
d) Improved care as a direct
consequence of CR participation
d) Efficiency of participation
with CR
d) Efficiency of participation
with CR
d) Number and proportion of patients
who sustain an adverse outcome
e) Improved care as an indirect effect
of CR
e) Clinician bankruptcy as a
consequence of involvement
with CR
e) RSO dropout from research
and financial difficulties
following participation in CR
e) Number and proportion of patients
who are subjects of Institutional Review
Board infractions
f) Patient satisfaction and trust with CR f) Clinician satisfaction with CR f) RSO satisfaction with CR f) Effect of biomedical research findings
on the practice of medicine
g) Outcomes associated with the
conduct of CR
g) Stability of clinician as a
participant in CR
g) Stability of RSOs as a
participant in CR
g) Effect of biomedical research findings
on the health of the people
h) Repeat participation of
clinicians in CR
h) Long-term CR capabilities
i) Degree of public trust
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research capacity and improve the quality of care over
time. It represents a long-term investment in the
research enterprise, with success depending upon lea-
dership, commitment, and support from stakeholders
already engaged and invested in research. If we want to
engage community clinicians in research on a large
scale, can we afford not to do this?
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